Ecolab (ECL) Tops Q3 EPS by 2c

Ecolab (NYSE: ECL) reported Q3 EPS of $1.15, $0.02 better than the analyst estimate of $1.13. Revenue for the quarter came in at $3.02 billion versus the consensus estimate of $3 billion.

Business Outlook

The continued uncertain outlook regarding the full extent of COVID-19’s impact on the global economy and its longevity do not yet provide an adequate basis for us to provide either quarterly or annual earnings forecasts.

We expect full year 2020 Healthcare & Life Sciences segment sales to show strong growth over the prior year, with modest pressure on our Industrial segment business sales and lessening but still significant pressure on results for our Institutional & Specialty and Other segments, with the COVID-19 impact on restaurant, hospitality and entertainment to result in a significant decline for the Institutional division sales within the Institutional & Specialty segment for the full year. We expect sequential improvement from third quarter levels as our product and service innovation, investments in new hygiene and digital technologies, and successful sales and profit initiatives augment a continuing recovery in customer activity.

For earnings history and earnings-related data on Ecolab (ECL) click here.

You May Also Be Interested In

• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
• Teradyne (TER) Tops Q1 EPS by 18c
• Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c